Literature DB >> 25991228

Designing the user interfaces of a behavior modification intervention for obesity & eating disorders prevention.

Ioannis Moulos1, Christos Maramis1, Alexandros Mourouzis1, Nicos Maglaveras1.   

Abstract

The recent immense diffusion of smartphones has significantly upgraded the role of mobile user interfaces in interventions that build and/or maintain healthier lifestyles. Indeed, high-quality, user-centered smartphone applications are able to serve as advanced front-ends to such interventions. These smartphone applications, coupled with portable or wearable sensors, are being employed for monitoring day to day health-related behaviors, including eating and physical activity. Some of them take one step forward by identifying unhealthy behaviors and contributing towards their modification. This work presents the design as well as the preliminary implementation of the mobile user interface of SPLENDID, a novel, sensor-oriented intervention for preventing obesity and eating disorders in young populations. This is implemented by means of an Android application, which is able to monitor the eating and physical activity behaviors of young individuals at risk for obesity and/or eating disorders, subsequently guiding them towards the modification of those behaviors that put them at risk. Behavior monitoring is based on multiple data provided by a set of communicating sensors and self-reported information, while guidance is facilitated through a feedback/encouragement provision and goal setting mechanism.

Entities:  

Mesh:

Year:  2015        PMID: 25991228

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  1 in total

1.  ACTonHEALTH study protocol: promoting psychological flexibility with activity tracker and mHealth tools to foster healthful lifestyle for obesity and other chronic health conditions.

Authors:  Roberto Cattivelli; Gianluca Castelnuovo; Alessandro Musetti; Giorgia Varallo; Chiara A M Spatola; Francesco Vailati Riboni; Anna Guerrini Usubini; Fabio Tosolin; Gian Mauro Manzoni; Paolo Capodaglio; Alessandro Rossi; Giada Pietrabissa; Enrico Molinari
Journal:  Trials       Date:  2018-11-29       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.